OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HOCL$34.4657

Hindustan Organic Chemicals Ltd

Commodity ChemicalsVerified

Hindustan Organic Chemicals has a market price of ₹34.46 and a market cap of ₹2.31 billion, with a price-to-earnings ratio of 0.59 and a price-to-book ratio of 0.22. The company's liquidity position is characterized by a current ratio of 3.61, indicating strong short-term liquidity, but its cash and equivalents of ₹3.09 million are significantly lower than its long-term debt of ₹2.06 billion. The debt-to-equity ratio of 0.2 suggests a conservative capital structure, with total liabilities of ₹5.19 billion and total equity of ₹10.45 billion. The company's profitability is robust, with a return on equity of 37.48% and a return on assets of 25.04%, both exceeding the typical thresholds for the Commodity Chemicals industry. Operating income of ₹4.19 billion and net income of ₹3.92 billion reflect strong margins, with a gross profit of ₹985.37 million on revenue of ₹5.36 billion. These metrics suggest the company is efficiently managing its production and cost structures. Hindustan Organic Chemicals operates in a single business segment, with no disclosed geographic diversification in the provided data. The company's revenue is entirely attributed to its domestic operations, indicating a high concentration risk in the Indian market. There are no segment-specific disclosures to suggest diversification across product lines or geographic regions. The company's growth trajectory is supported by strong operating cash flow of ₹6.31 billion and free cash flow of ₹3.86 billion, which provide flexibility for reinvestment or debt reduction. Capital expenditures of -₹72.26 million suggest a reduction in capital spending, which may indicate a focus on maintaining existing operations rather than expansion. The outlook for the current fiscal year is positive, with the company likely to maintain its profitability and liquidity position. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. The company's net cash position is negative after subtracting total debt, which could pose a challenge if cash flow from operations were to decline. However, the low dilution risk and strong free cash flow mitigate this concern. The company has not disclosed any recent events or filings that would suggest a material change in its risk profile. There are no recent filings or transcripts disclosed in the provided data that would indicate significant changes in the company's operations or strategy. The company's financial performance and risk profile appear to be stable, with no immediate signs of distress or transformation.

30-day price · HOCL+7.65 (+29.4%)
Low$21.05High$36.00Close$33.67As of11 May, 00:00 UTC
Profile
CompanyHindustan Organic Chemicals Ltd
TickerHOCL.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Hindustan Organic Chemicals Limited produces and sells industrial chemicals and chemical intermediates, including Phenol, Acetone, and Hydrogen Peroxide, which are used in resins, pharmaceuticals, solvents, and bleaching applications.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Hindustan Organic Chemicals has a market price of ₹34.46 and a market cap of ₹2.31 billion, with a price-to-earnings ratio of 0.59 and a price-to-book ratio of 0.22. The company's liquidity position is characterized by a current ratio of 3.61, indicating strong short-term liquidity, but its cash and equivalents of ₹3.09 million are significantly lower than its long-term debt of ₹2.06 billion. The debt-to-equity ratio of 0.2 suggests a conservative capital structure, with total liabilities of ₹5.19 billion and total equity of ₹10.45 billion. The company's profitability is robust, with a return on equity of 37.48% and a return on assets of 25.04%, both exceeding the typical thresholds for the Commodity Chemicals industry. Operating income of ₹4.19 billion and net income of ₹3.92 billion reflect strong margins, with a gross profit of ₹985.37 million on revenue of ₹5.36 billion. These metrics suggest the company is efficiently managing its production and cost structures. Hindustan Organic Chemicals operates in a single business segment, with no disclosed geographic diversification in the provided data. The company's revenue is entirely attributed to its domestic operations, indicating a high concentration risk in the Indian market. There are no segment-specific disclosures to suggest diversification across product lines or geographic regions. The company's growth trajectory is supported by strong operating cash flow of ₹6.31 billion and free cash flow of ₹3.86 billion, which provide flexibility for reinvestment or debt reduction. Capital expenditures of -₹72.26 million suggest a reduction in capital spending, which may indicate a focus on maintaining existing operations rather than expansion. The outlook for the current fiscal year is positive, with the company likely to maintain its profitability and liquidity position. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. The company's net cash position is negative after subtracting total debt, which could pose a challenge if cash flow from operations were to decline. However, the low dilution risk and strong free cash flow mitigate this concern. The company has not disclosed any recent events or filings that would suggest a material change in its risk profile. There are no recent filings or transcripts disclosed in the provided data that would indicate significant changes in the company's operations or strategy. The company's financial performance and risk profile appear to be stable, with no immediate signs of distress or transformation.
Key takeaways
  • Hindustan Organic Chemicals has a strong return on equity of 37.48% and a return on assets of 25.04%, indicating efficient use of capital.
  • The company's liquidity position is strong, with a current ratio of 3.61 and a debt-to-equity ratio of 0.2.
  • The company's revenue is entirely concentrated in its domestic operations, indicating a high geographic concentration risk.
  • The company has a robust operating cash flow of ₹6.31 billion and free cash flow of ₹3.86 billion, providing flexibility for reinvestment or debt reduction.
  • The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$5.36B
Gross profit$985.4M
Operating income$4.19B
Net income$3.92B
R&D
SG&A
D&A
SBC
Operating cash flow$6.31B
CapEx-$72.3M
Free cash flow$3.86B
Total assets$15.64B
Total liabilities$5.19B
Total equity$10.45B
Cash & equivalents$3.1M
Long-term debt$2.06B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$34.46
Market cap$2.31B
Enterprise value$4.38B
P/E0.6
Reported non-GAAP P/E
EV/Revenue0.8
EV/Op income1.1
EV/OCF0.7
P/B0.2
P/Tangible book0.2
Tangible book$10.45B
Net cash-$2.06B
Current ratio3.6
Debt/Equity0.2
ROA25.0%
ROE37.5%
Cash conversion1.6%
CapEx/Revenue-1.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricHOCLActivity
Op margin78.1%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin73.1%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin18.4%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity20.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 12:48 UTC#af15f61e
Market quoteclose INR 34.46 · shares 0.07B diluted
no public URL
2026-05-10 12:48 UTC#1309969f
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 12:51 UTCJob: 843ea504